• UCSBgauchos twitter avatar
    Softball: Gauchos Split Final Road Games at Hawai'i https://t.co/CpEDdmmhVc
    8 hours 58 min ago
  • UCSBgauchos twitter avatar
    Gauchos are live on @ESPN3 ! WATCH >>> https://t.co/io6ZzYs9Hg https://t.co/BEO8wTxv62
    14 hours 5 min ago
  • ucsantabarbara twitter avatar
    Congrats to Leah Foltz for winning the #UCSB Grad Slam! Now she moves onto the UC-wide competition in SF on May 4th! https://t.co/kVqCtOTWb7
    20 hours 59 min ago
  • UCSBgauchos twitter avatar
    Former @UCSB_Baseball LHP Dom Mazza speaks with his hometown paper after throwing a perfecto this week! https://t.co/GPc3B3qL9g
    21 hours 18 min ago
  • ArtsandLectures twitter avatar
    Watch pianist #MurrayPerahia's breathtaking and imaginative performance, tonight at 7PM at UCSB Campbell Hall!… https://t.co/M83EeA6Y53
    1 day 4 min ago
  • UCSBgauchos twitter avatar
    Softball: Hawai'i Tops UCSB 5-1 in Gauchos' Final Road Series Opener https://t.co/ejf0MWM1g0
    1 day 7 hours ago
  • UCSBgauchos twitter avatar
    Gauchos Sweep Past UCI 4-0 https://t.co/WFwbxDV8eA
    1 day 10 hours ago
  • ucsantabarbara twitter avatar
    We're happy to see you back, alumni! Don't miss the great events we have this weekend. #AllGauchoReunion… https://t.co/Sbz4iirr7i
    1 day 13 hours ago
  • UCSBgauchos twitter avatar
    Women's Tennis: Cal Poly 0, UC Santa Barb. 4 (Final) No.2 UCSB blanks No.7 Cal Poly in Big West Quarterfinal 4-0 https://t.co/m4kdACQFo5
    1 day 13 hours ago
  • UCSBgauchos twitter avatar
    .@UCSB_Baseball vs. UC Riverside on @ESPN3 is live now! Watch here >>> https://t.co/QJMvNLa0mQ
    1 day 14 hours ago
  • UCSBgauchos twitter avatar
    WWP: Defending Big West Champs Defeated by No. 12 LBSU in Another Overtime Match https://t.co/XIO3RJdo9p
    1 day 14 hours ago
  • UCSBgauchos twitter avatar
    Top-Seeded UCSB Set to Host Big West Golf Championship at Sandpiper GC https://t.co/SyXPKB2Ur5
    1 day 15 hours ago
  • UCSBLibrary twitter avatar
    RT @ForestSways: CEMA poster preservation for primary source research. #Chicanohertiage @Marikhasmanyan @UCSBLibrary #sca17 https://t.co/M…
    1 day 17 hours ago
  • UCSBLibrary twitter avatar
    @AmldavisAnn We're glad you're interested in using, please contact (805) 893-3062 or @library.ucsb.edu">special@library.ucsb.edu for m… https://t.co/fwAVOMoWyB
    1 day 17 hours ago
  • UCSB_GradPost twitter avatar
    CPT F-1 Visa workshop for international students on May 11 https://t.co/l6xZEndRVl #UCSB #ucsbgradpost
    1 day 18 hours ago

A Paradigm Shift in Multidrug Resistance

Michael Mahan discovers an unexpected resistance mechanism in pathogenic bacteria that may warrant changes in the way antibiotics are developed, tested and prescribed
Thursday, August 20, 2015 - 10:15
Santa Barbara, CA
Bacteria that respond to antibiotics in the lab can become resistant in the body.

Trojan horse CROPPED.jpg

Trojan horse illustration

Bacteria switch between antibiotic susceptible-to-resistant states during infection using a Trojan horse strategy.

Photo Credit: 

ILLUSTRATION BY PETER ALLEN

Mahan, Heithoff, Ersoy.jpg

Mahan, Heithoff and Ersoy

Co-authors: Michael Mahan (left), Douglas Heithoff and Selvi Ersoy.

Photo Credit: 

Spencer Bruttig

Bacteria are pretty wily creatures. Take for example, an organism such as Salmonella, which succumbs to antibiotics in lab tests, but can become highly resistant in the body.

It is an example of what UC Santa Barbara biologist Michael Mahan refers to as the Trojan horse strategy. Identified through new research conducted by Mahan and his colleagues, the Trojan horse strategy may explain why antibiotics are ineffective in some patients despite lab tests that predict otherwise. The research findings appear in the journal EBioMedicine.

“We are not petri plates, and we need to revisit the way antibiotics are developed, tested and prescribed,” said Mahan, a professor in UCSB’s Department of Molecular, Cellular, and Developmental Biology. Current methods for testing resistance to antibiotics do not reflect the actual and varying environments in the body, where bacteria fight to survive. Mahan noted that this difference can render antibiotic susceptibility testing inaccurate.

“Prescription of the wrong antibiotic may not only fail to clear the infection but may create the perfect storm for the emergence of superbugs in infected patients,” he added. “Even in our most advanced hospitals, high drug doses are given to infected patients without knowing that the body’s environment may render bacteria inherently resistant to the very antibiotics prescribed to control them.” 

Mahan’s research demonstrates two important points: Bacteria become resistant only to certain antibiotics, and they deploy this defense mechanism only in certain areas of the body. This means that when a patient fails to respond to a particular course of antibiotics that lab tests predict should be effective, rather than increasing the dose or duration of treatment, a potentially more effective therapeutic option is simply to prescribe another drug.

Mahan and his colleagues initially worked with the aforementioned Salmonella, a bacterium that causes food and blood poisoning. Salmonella reside within white blood cells — the very cells of the immune system that are involved in protecting the body against infectious disease. When the researchers mimicked this intracellular environment in the lab, the bacteria became highly resistant to certain antibiotics.

Next, the researchers tested Yersinia, a bacterium that also causes food and blood poisoning but lives outside of host cells in the intestine. When researchers mimicked the extracellular environment of the intestine, this bacterium also became highly resistant to certain antibiotics. These two examples indicate that the resistance process may be shared by many different types of bacteria.

“Our research suggests the need for animal models to be incorporated early during the antibiotic development process and for lab drug sensitivity testing to incorporate media that mimic the specific biochemical environments that trigger resistance in the body,” Mahan explained. “If these additional components were added, we’d get a more accurate reflection of what happens when a patient is treated with a particular drug.

“An exciting potential outcome of this research is that the next wonder drug to treat multidrug-resistant superbugs may already exist at pharmaceutical companies, which store millions of chemical compounds,” Mahan added. “Some of these compounds may have been excluded as antibiotics since they did not kill bugs efficiently on petri plates, but they may work well in treating patients with multidrug-resistant infections.”

The lead authors of the paper are Jessica Kubicek-Sutherland, a former graduate student in the Mahan lab who is now a postdoctoral fellow at Uppsala University in Sweden, and Douglas Heithoff, a project scientist at the campus’s Center for Nanomedicine. Additional UCSB co-authors include Selvi Ersoy, a graduate student in the Mahan lab, and Jamey Marth, director of the Center for Nanomedicine and a MCDB professor. William Shimp, projects manager of ICON Clinical Research in La Jolla, California; John House of the University of Sydney in Australia; and Jeffrey Smith of the Sanford-Burnham Medical Research Institute in La Jolla, California, are also contributors. 

This work was supported by the G. Harold and Leila Y. Mathers Foundation, the Santa Barbara Cottage Hospital Research Program, the National Institutes of Health and a National Science Foundation Graduate Fellowship.

Contact Info: 

Julie Cohen
(805) 893-7220
julie.cohen@ucsb.edu

Topics: